Minarik Jiri, Krhovska Petra, Hrbek Jan, Pika Tomas, Bacovsky Jaroslav, Herman Miroslav, Scudla Vlastimil
Department of Hemato-Oncology, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech Republic.
Department of Radiology, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech Republic.
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2016 Jun;160(2):305-9. doi: 10.5507/bp.2015.064. Epub 2016 Jan 5.
We carried out a prospective study in order to identify the best imaging approach for patients with newly diagnosed multiple myeloma (MM) and monoclonal gammopathy of undetermined significance (MGUS).
We assessed the extent of myeloma bone disease (MBD) in 112 individuals - 84 patients with MM and 28 individuals with MGUS. For the detection of osteolytic involvement we used whole-body magnetic resonance imaging (WB-MRI), low-dose computed tomography (LD-CT) and conventional radiography (CR). Each method assessed the presence of osteolytic involvement, compressive fractures and extramedullary involvement in the following regions: skull, spine and chest, pelvis and humerus and femur. We compared the difference in the number and extent of osteolytic involvement, especially the findings in CR negative patients.
Conventional radiography showed no superiority in any of the evaluated regions, and failed in the detection of extramedullary massess and spine involvement. WB-MRI was best at imaging the spine including extramedullary involvement, however, detection of osteolytic lesions of the skull was limited in comparison with both CR and LD-CT. Both WB-MRI and LD-CT were comparable in imaging of lesions of pelvis, humerus, femur and the presence of extramedullary masses. LD-CT showed superiority in detection of skull lesions but lower sensitivity in spine compared to WB-MRI.
Our results confirm that relying solely on CR in the diagnostics of MM is insufficient. We suggest that the most suitable method for primary assessment of osteolytic involvement in monoclonal gammopathies should include either whole-body MRI together with CR of the skull or, with an equivalent sensitivity, whole body LD-CT.
我们开展了一项前瞻性研究,以确定新诊断的多发性骨髓瘤(MM)和意义未明的单克隆丙种球蛋白病(MGUS)患者的最佳成像方法。
我们评估了112例个体的骨髓瘤骨病(MBD)范围,其中包括84例MM患者和28例MGUS患者。为检测溶骨性病变,我们使用了全身磁共振成像(WB-MRI)、低剂量计算机断层扫描(LD-CT)和传统X线摄影(CR)。每种方法评估了以下区域溶骨性病变、压缩性骨折和髓外病变的存在情况:颅骨、脊柱和胸部、骨盆以及肱骨和股骨。我们比较了溶骨性病变数量和范围的差异,尤其是CR阴性患者的检查结果。
在任何评估区域中,传统X线摄影均未显示出优势,并且未能检测到髓外肿块和脊柱病变。WB-MRI在成像包括髓外病变的脊柱方面表现最佳,然而,与CR和LD-CT相比,其对颅骨溶骨性病变的检测有限。WB-MRI和LD-CT在骨盆、肱骨、股骨病变以及髓外肿块成像方面相当。LD-CT在检测颅骨病变方面显示出优势,但与WB-MRI相比,其在脊柱方面的敏感性较低。
我们的结果证实,在MM诊断中仅依靠CR是不够的。我们建议,对单克隆丙种球蛋白病溶骨性病变进行初步评估的最合适方法应包括全身MRI联合颅骨CR,或者具有同等敏感性的全身LD-CT。